A team of experts from the Centers for Disease Control and Prevention (CDC), the US health agency, argued that more data is needed and thus postponed the decision to continue vaccination with Johnson & Johnson after Preventive discontinuation on Tuesday by the US Regulatory Authority monitors rare cases of thrombosis in six women. The experts will meet in 7-10 days, according to US media. Instead, some FDA scientists have argued that the risks can be minimized with adequate warnings.
The postponement, which threatens to slow down vaccination plans in the US and Europe, is decided by the CDC advisory committee, a group of independent experts who think more time is needed to fight. data prices and risk before voting. their own recommendations.
INTRODUCTION RESERVED © Copyright ANSA